Last 12 months
Inside the activity.
9 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 1 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 17, 2026 22:32 UTC |
Bowman Ronald LeeChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,566 | $0.00 | $0.00 |
DisclosureSEC source: 0002036238-26-000005 · wk-form4_1789684328.xml · derivative · entry 3 Bowman Ronald Lee · CIK 0002036238 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,566 Underlying: Common Stock · 2,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 2,565 shares vested on September 15, 2025; 2,566 shares vested on September 15, 2026; and the remaining 2,566 shares will vest on September 15, 2027. F4 · derivative.expiration_date: 2,565 shares vested on September 15, 2025; 2,566 shares vested on September 15, 2026; and the remaining 2,566 shares will vest on September 15, 2027. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 22:32 UTC |
Bowman Ronald LeeChief Human Resources Officer
|
Tax withholdingCommon Stock | 921 | $10.63 | $9,790.23 |
DisclosureSEC source: 0002036238-26-000005 · wk-form4_1789684328.xml · nonDerivative · entry 2 Bowman Ronald Lee · CIK 0002036238 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,020 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 22:32 UTC |
Bowman Ronald LeeChief Human Resources Officer
|
Exercise / conversionCommon Stock | 2,566 | $0.00 | $0.00 |
DisclosureSEC source: 0002036238-26-000005 · wk-form4_1789684328.xml · nonDerivative · entry 1 Bowman Ronald Lee · CIK 0002036238 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:14 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
Exercise / conversionRestricted Stock Units · Derivative | 446 | $0.00 | $0.00 |
DisclosureSEC source: 0002123618-26-000011 · wk-form4_1787084082.xml · derivative · entry 3 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 446 shares vested on August 15, 2026. F4 · derivative.expiration_date: 446 shares vested on August 15, 2026. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:14 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
Tax withholdingCommon Stock | 162 | $14.30 | $2,316.60 |
DisclosureSEC source: 0002123618-26-000011 · wk-form4_1787084082.xml · nonDerivative · entry 2 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,055 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:14 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
Exercise / conversionCommon Stock | 446 | $0.00 | $0.00 |
DisclosureSEC source: 0002123618-26-000011 · wk-form4_1787084082.xml · nonDerivative · entry 1 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:20 UTC |
Young Micah WChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 356,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001717871-26-000006 · wk-form4_1784233208.xml · derivative · entry 1 Young Micah W · CIK 0001717871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,555 Underlying: Common Stock · 356,555 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 118,851 shares will vest on July 15, 2027, 118,852 shares will vest on July 15, 2028, and 118,852 shares will vest on July 15, 2029. F2 · derivative.expiration_date: 118,851 shares will vest on July 15, 2027, 118,852 shares will vest on July 15, 2028, and 118,852 shares will vest on July 15, 2029. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:06 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
Exercise / conversionRestricted Stock Units · Derivative | 5,797 | $0.00 | $0.00 |
DisclosureSEC source: 0002123618-26-000009 · wk-form4_1783022797.xml · derivative · entry 3 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,595 Underlying: Common Stock · 5,797 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 5,797 shares vested on July 1, 2026, 5,797 shares will vest on July 1, 2027 and 5,798 shares will vest on July 1, 2028. F4 · derivative.expiration_date: 5,797 shares vested on July 1, 2026, 5,797 shares will vest on July 1, 2027 and 5,798 shares will vest on July 1, 2028. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:06 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
Tax withholdingCommon Stock | 2,096 | $18.18 | $38,105.28 |
DisclosureSEC source: 0002123618-26-000009 · wk-form4_1783022797.xml · nonDerivative · entry 2 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,771 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:06 UTC |
Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
|
Exercise / conversionCommon Stock | 5,797 | $0.00 | $0.00 |
DisclosureSEC source: 0002123618-26-000009 · wk-form4_1783022797.xml · nonDerivative · entry 1 Hanson Bryan Michael · CIK 0002123618 · EVP Global Port. Mgmt & Mkting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:01 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 1,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001065168-26-000006 · wk-form4_1782770501.xml · derivative · entry 3 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,997 Underlying: Common Stock · 1,997 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:01 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 6,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001065168-26-000006 · wk-form4_1782770501.xml · derivative · entry 2 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,656 Underlying: Common Stock · 6,656 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: 1,664 shares vested on June 25, 2026, 1,664 shares will vest on September 25, 2026, 1,664 shares will vest on December 25, 2026, and 1,664 shares will vest on March 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: 1,664 shares vested on June 25, 2026, 1,664 shares will vest on September 25, 2026, 1,664 shares will vest on December 25, 2026, and 1,664 shares will vest on March 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:01 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001065168-26-000006 · wk-form4_1782770501.xml · derivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,532 Underlying: Common Stock · 15,532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:00 UTC |
Chiminski John RDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 1,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001482197-26-000003 · wk-form4_1782770418.xml · derivative · entry 3 Chiminski John R · CIK 0001482197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,109 Underlying: Common Stock · 1,109 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:00 UTC |
Chiminski John RDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001482197-26-000003 · wk-form4_1782770418.xml · derivative · entry 2 Chiminski John R · CIK 0001482197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,547 Underlying: Common Stock · 5,547 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:00 UTC |
Chiminski John RDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001482197-26-000003 · wk-form4_1782770418.xml · derivative · entry 1 Chiminski John R · CIK 0001482197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,532 Underlying: Common Stock · 15,532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:56 UTC |
BUECHLER KENNETH FDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 3,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001238916-26-000005 · wk-form4_1782770157.xml · derivative · entry 3 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,661 Underlying: Common Stock · 3,661 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:56 UTC |
BUECHLER KENNETH FDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 12,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001238916-26-000005 · wk-form4_1782770157.xml · derivative · entry 2 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,204 Underlying: Common Stock · 12,204 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: 3,051 shares vested on June 25, 2026, 3,051 shares will vest on September 25, 2026, 3,051 shares will vest on December 25, 2026, and 3,051 shares will vest on March 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: 3,051 shares vested on June 25, 2026, 3,051 shares will vest on September 25, 2026, 3,051 shares will vest on December 25, 2026, and 3,051 shares will vest on March 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:56 UTC |
BUECHLER KENNETH FDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001238916-26-000005 · wk-form4_1782770157.xml · derivative · entry 1 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,532 Underlying: Common Stock · 15,532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:59 UTC |
POLAN MARY LAKE PH DDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 1,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000005 · wk-form4_1782770339.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,664 Underlying: Common Stock · 1,664 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:59 UTC |
POLAN MARY LAKE PH DDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000005 · wk-form4_1782770339.xml · derivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,547 Underlying: Common Stock · 5,547 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:59 UTC |
POLAN MARY LAKE PH DDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000005 · wk-form4_1782770339.xml · derivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,532 Underlying: Common Stock · 15,532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:59 UTC |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 369 | $0.00 | $0.00 |
DisclosureSEC source: 0001250252-26-000007 · wk-form4_1782770364.xml · derivative · entry 3 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369 Underlying: Common Stock · 369 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:59 UTC |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 3,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001250252-26-000007 · wk-form4_1782770364.xml · derivative · entry 2 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,698 Underlying: Common Stock · 3,698 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: 924 shares vested on June 25, 2026, 924 shares will vest on September 25, 2026, 925 shares will vest on December 25, 2026, and 925 shares will vest on March 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: 924 shares vested on June 25, 2026, 924 shares will vest on September 25, 2026, 925 shares will vest on December 25, 2026, and 925 shares will vest on March 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:59 UTC |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001250252-26-000007 · wk-form4_1782770364.xml · derivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,532 Underlying: Common Stock · 15,532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 22:00 UTC |
Huennekens R ScottDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001365493-26-000008 · wk-form4_1782770440.xml · derivative · entry 1 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,532 Underlying: Common Stock · 15,532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:57 UTC |
Dilsaver Evelyn SDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001391387-26-000010 · wk-form4_1782770268.xml · derivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,532 Underlying: Common Stock · 15,532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:58 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Premium) · Derivative | 1,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001391823-26-000005 · wk-form4_1782770311.xml · derivative · entry 3 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,053 Underlying: Common Stock · 1,053 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:58 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Converted) · Derivative | 3,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001391823-26-000005 · wk-form4_1782770311.xml · derivative · entry 2 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,513 Underlying: Common Stock · 3,513 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: 878 shares vested on June 25, 2026, 878 shares will vest on September 25, 2026, 878 shares will vest on December 25, 2026, and 879 shares will vest on March 25, 2027. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: 878 shares vested on June 25, 2026, 878 shares will vest on September 25, 2026, 878 shares will vest on December 25, 2026, and 879 shares will vest on March 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:58 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001391823-26-000005 · wk-form4_1782770311.xml · derivative · entry 1 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,532 Underlying: Common Stock · 15,532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:59 UTC |
Wilkins Joseph D Jr.Director
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 15,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001848760-26-000003 · wk-form4_1782770397.xml · derivative · entry 1 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,532 Underlying: Common Stock · 15,532 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units will vest on June 25, 2027. F2 · derivative.expiration_date: The restricted stock units will vest on June 25, 2027. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:07 UTC |
WIDDER KENNETH JDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0001065168-26-000005 · wk-form4_1781035629.xml · derivative · entry 4 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:07 UTC |
WIDDER KENNETH JDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001065168-26-000005 · wk-form4_1781035629.xml · derivative · entry 3 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 910 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:07 UTC |
WIDDER KENNETH JDirector
|
GrantCommon Stock | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0001065168-26-000005 · wk-form4_1781035629.xml · nonDerivative · entry 2 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,073 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:07 UTC |
WIDDER KENNETH JDirector
|
GrantCommon Stock | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001065168-26-000005 · wk-form4_1781035629.xml · nonDerivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,800 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC |
BUECHLER KENNETH FDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 497 | $0.00 | $0.00 |
DisclosureSEC source: 0001238916-26-000004 · wk-form4_1781035566.xml · derivative · entry 4 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 497 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC |
BUECHLER KENNETH FDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 1,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001238916-26-000004 · wk-form4_1781035566.xml · derivative · entry 3 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,659 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC |
BUECHLER KENNETH FDirector
|
GrantCommon Stock | 497 | $0.00 | $0.00 |
DisclosureSEC source: 0001238916-26-000004 · wk-form4_1781035566.xml · nonDerivative · entry 2 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,906 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC |
BUECHLER KENNETH FDirector
|
GrantCommon Stock | 1,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001238916-26-000004 · wk-form4_1781035566.xml · nonDerivative · entry 1 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,409 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC |
POLAN MARY LAKE PH DDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000004 · wk-form4_1781035597.xml · derivative · entry 5 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC |
POLAN MARY LAKE PH DDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000004 · wk-form4_1781035597.xml · derivative · entry 4 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 749 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC |
POLAN MARY LAKE PH DDirector
|
GrantCommon Stock | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000004 · wk-form4_1781035597.xml · nonDerivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,442 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:06 UTC |
POLAN MARY LAKE PH DDirector
|
GrantCommon Stock | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0001187716-26-000004 · wk-form4_1781035597.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,218 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:05 UTC |
Michael Edward L.Director
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 289 | $0.00 | $0.00 |
DisclosureSEC source: 0001391823-26-000004 · wk-form4_1781035528.xml · derivative · entry 4 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 289 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:05 UTC |
Michael Edward L.Director
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 963 | $0.00 | $0.00 |
DisclosureSEC source: 0001391823-26-000004 · wk-form4_1781035528.xml · derivative · entry 3 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 963 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:05 UTC |
Michael Edward L.Director
|
GrantCommon Stock | 289 | $0.00 | $0.00 |
DisclosureSEC source: 0001391823-26-000004 · wk-form4_1781035528.xml · nonDerivative · entry 2 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,433 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:05 UTC |
Michael Edward L.Director
|
GrantCommon Stock | 963 | $0.00 | $0.00 |
DisclosureSEC source: 0001391823-26-000004 · wk-form4_1781035528.xml · nonDerivative · entry 1 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,144 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:10 UTC |
WIDDER KENNETH JDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001065168-26-000003 · wk-form4_1780431045.xml · derivative · entry 2 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:10 UTC |
WIDDER KENNETH JDirector
|
GrantCommon Stock | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001065168-26-000003 · wk-form4_1780431045.xml · nonDerivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,890 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:09 UTC |
Chiminski John RDirector
|
Exercise / conversionRestricted Stock Units (Equity Grant) · Derivative | 6,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001482197-26-000002 · wk-form4_1780430962.xml · derivative · entry 2 Chiminski John R · CIK 0001482197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,829 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vested on May 29, 2026. F3 · derivative.expiration_date: The restricted stock units vested on May 29, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.